<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>tinyBuild Archives - UK Investor Magazine</title>
	<atom:link href="https://ukinvestormagazine.co.uk/tag/tinybuild/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/tag/tinybuild/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Tue, 16 Sep 2025 11:32:00 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>

<image>
	<url>https://ukinvestormagazine.co.uk/wp-content/uploads/2025/05/cropped-favicon-96-96-32x32.jpg</url>
	<title>tinyBuild Archives - UK Investor Magazine</title>
	<link>https://ukinvestormagazine.co.uk/tag/tinybuild/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>AIM moves: Focusrite improves revenues and Manolete Partners expects significant second half weighting</title>
		<link>https://ukinvestormagazine.co.uk/aim-moves-focusrite-improves-revenues-and-manolete-partners-expects-significant-second-half-weighting/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-moves-focusrite-improves-revenues-and-manolete-partners-expects-significant-second-half-weighting/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Tue, 16 Sep 2025 11:21:25 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Fiinu]]></category>
		<category><![CDATA[Focusrite]]></category>
		<category><![CDATA[kromek]]></category>
		<category><![CDATA[Manolete Partners]]></category>
		<category><![CDATA[Manx Financial]]></category>
		<category><![CDATA[Silver Bullet Data Services]]></category>
		<category><![CDATA[Star Energy]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=83419</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-1024x683.jpg 1024w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-1536x1024.jpg 1536w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-2048x1366.jpg 2048w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-1260x840.jpg 1260w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-600x400.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-696x464.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-1392x928.jpg 1392w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-1068x712.jpg 1068w, https://ukinvestormagazine.co.uk/wp-content/uploads/2025/09/L-Devine-artist-on-guitar-with-Focusrite-Scarlett-2i2-1920x1280.jpg 1920w" sizes="(max-width: 300px) 100vw, 300px" /><p>Digital marketing services provider Silver Bullet Data Services (LON: SBDS) has appointed Dara Nasr as a non-executive director. He was previously a vice president at We Transfer. Martyn Rattle and AnnaMaria Khan-Rubalcaba have stepped down from the board. The share price increased 38.7% to 2.15p. Audio products supplier Focusrite (LON: TUNE) performed strongly in the [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-moves-focusrite-improves-revenues-and-manolete-partners-expects-significant-second-half-weighting/">AIM moves: Focusrite improves revenues and Manolete Partners expects significant second half weighting</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-moves-focusrite-improves-revenues-and-manolete-partners-expects-significant-second-half-weighting/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Empyrean Energy reveals Mako progress and Beacon Energy disappoints</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-empyrean-energy-reveals-mako-progress-and-beacon-energy-disappoints/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-empyrean-energy-reveals-mako-progress-and-beacon-energy-disappoints/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Mon, 24 Jun 2024 10:37:09 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Aptamer]]></category>
		<category><![CDATA[Ariana Resources]]></category>
		<category><![CDATA[Beacon Energy]]></category>
		<category><![CDATA[Belluscura]]></category>
		<category><![CDATA[Directa Plus]]></category>
		<category><![CDATA[Empyrean]]></category>
		<category><![CDATA[Kore Potash]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=73571</guid>

					<description><![CDATA[<img width="300" height="150" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/FTSE-250-19042022-300x150.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/FTSE-250-19042022-300x150.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/FTSE-250-19042022-768x384.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/FTSE-250-19042022-150x75.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/FTSE-250-19042022-600x300.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/FTSE-250-19042022-696x348.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/FTSE-250-19042022-840x420.jpg 840w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/FTSE-250-19042022.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Oil and gas company Empyrean Energy (LON: EME) says the Mako joint venture, where it has a 8.5% participating interest, has entered a binding gas sale agreement with PGN for the domestic portion of gas from the Mako field in Indonesia. The deal is subject to the construction of a gas pipeline. This covers 122.8 [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-empyrean-energy-reveals-mako-progress-and-beacon-energy-disappoints/">AIM movers: Empyrean Energy reveals Mako progress and Beacon Energy disappoints</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-empyrean-energy-reveals-mako-progress-and-beacon-energy-disappoints/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Bushveld Minerals concerned by Vanadium price and Sareum ends loan facility</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-bushveld-minerals-concerned-by-vanadium-price-and-sareum-ends-loan-facility/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-bushveld-minerals-concerned-by-vanadium-price-and-sareum-ends-loan-facility/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Tue, 23 Apr 2024 11:09:39 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[88 Energy]]></category>
		<category><![CDATA[Bens Creek]]></category>
		<category><![CDATA[Bushveld Minerals]]></category>
		<category><![CDATA[corcel]]></category>
		<category><![CDATA[GB Group]]></category>
		<category><![CDATA[RWS]]></category>
		<category><![CDATA[Sareum]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<category><![CDATA[Trellus Health]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=72451</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2018/12/Bushveld-Minerals-Vanadium-price-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2018/12/Bushveld-Minerals-Vanadium-price-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/12/Bushveld-Minerals-Vanadium-price-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/12/Bushveld-Minerals-Vanadium-price-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/12/Bushveld-Minerals-Vanadium-price-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/12/Bushveld-Minerals-Vanadium-price-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/12/Bushveld-Minerals-Vanadium-price-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/12/Bushveld-Minerals-Vanadium-price.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Cancer treatments developer Sareum (LON: SAR) no longer has an outstanding facility with RiverFort Global Opportunities PCC following the issue of 2.26 million shares. No more withdrawals will be made. That has pleased investors and the share price jumped 24.7% to 29p and it is 75.8% higher over five days. A year-end trading statement from [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-bushveld-minerals-concerned-by-vanadium-price-and-sareum-ends-loan-facility/">AIM movers: Bushveld Minerals concerned by Vanadium price and Sareum ends loan facility</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-bushveld-minerals-concerned-by-vanadium-price-and-sareum-ends-loan-facility/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AIM weekly movers: Helium One Global shares fall below placing price</title>
		<link>https://ukinvestormagazine.co.uk/aim-weekly-movers-helium-one-global-shares-fall-below-placing-price/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-weekly-movers-helium-one-global-shares-fall-below-placing-price/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Sat, 23 Dec 2023 01:15:52 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[ADVFN]]></category>
		<category><![CDATA[Bidstack]]></category>
		<category><![CDATA[cap-xx]]></category>
		<category><![CDATA[GCM Resources]]></category>
		<category><![CDATA[Helium One Global]]></category>
		<category><![CDATA[Mindflair]]></category>
		<category><![CDATA[RBG Holdings]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=70384</guid>

					<description><![CDATA[<img width="300" height="286" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-440x420.jpg 440w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-640x610.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-681x649.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market.jpg 885w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Bidstack (LON: BIDS) has sorted out its problem with Azerion and the share price more than doubled to 0.75p. The in-game advertising technology provider has reached a settlement with Azerion, which will pay €3m to Bidstack. The two parties will form a new non-exclusive commercial partnership in 2024. Video games publisher tinyBuild (LON: TBLD) has [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-weekly-movers-helium-one-global-shares-fall-below-placing-price/">AIM weekly movers: Helium One Global shares fall below placing price</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-weekly-movers-helium-one-global-shares-fall-below-placing-price/feed/</wfw:commentRss>
			<slash:comments>5</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: tinyBuild secures cash and ex-dividends</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-tinybuild-secures-cash-and-ex-dividends/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-tinybuild-secures-cash-and-ex-dividends/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Thu, 21 Dec 2023 12:01:39 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[ADVFN]]></category>
		<category><![CDATA[Caspian Sunrise]]></category>
		<category><![CDATA[europa oil and gas]]></category>
		<category><![CDATA[GlobalData]]></category>
		<category><![CDATA[Helium One Global]]></category>
		<category><![CDATA[Scirocco Energy]]></category>
		<category><![CDATA[SRT Marine]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=70367</guid>

					<description><![CDATA[<img width="300" height="195" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-300x195.png" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-300x195.png 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-1024x667.png 1024w, https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-768x500.png 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-150x98.png 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-600x391.png 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-696x453.png 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-1392x906.png 1392w, https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-1068x695.png 1068w, https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-645x420.png 645w, https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares-1290x840.png 1290w, https://ukinvestormagazine.co.uk/wp-content/uploads/2023/06/Tinybuild-shares.png 1496w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Video games publisher tinyBuild (LON: TBLD) has secured the cash it requires for working capital. The fundraising includes a one-for-six open offer and should raise $14m at 5p/share. The share price recovered 50% to 3.75p. Interactive entertainment company Atari is investing $2m. Chief executive Alex Nichiporchik will underwrite up to $10m of the fundraising. The [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-tinybuild-secures-cash-and-ex-dividends/">AIM movers: tinyBuild secures cash and ex-dividends</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-tinybuild-secures-cash-and-ex-dividends/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AIM weekly movers: Another positive statement from Cornerstone FS</title>
		<link>https://ukinvestormagazine.co.uk/aim-weekly-movers-another-positive-statement-from-cornerstone-fs/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-weekly-movers-another-positive-statement-from-cornerstone-fs/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Sun, 10 Dec 2023 01:13:09 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Cornerstone FS]]></category>
		<category><![CDATA[Future Metals]]></category>
		<category><![CDATA[Genedrive]]></category>
		<category><![CDATA[Myanmar Investments]]></category>
		<category><![CDATA[Petards]]></category>
		<category><![CDATA[Sancus Lending]]></category>
		<category><![CDATA[Smart Metering Systems]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=69999</guid>

					<description><![CDATA[<img width="300" height="286" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-440x420.jpg 440w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-640x610.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-681x649.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market.jpg 885w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Pharmacogenetic testing company GeneDrive (LON: GDR) says the Royal Sussex County Hospital in Brighton is adopting the MT-RNR1 ID kit in its baby unit. This is the second NHS trust to use the kit for antibiotic induced hearing loss testing. The share price jumped 60.9% to 9,25p. Payments services provider Cornerstone FS (LON: CSFS) published [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-weekly-movers-another-positive-statement-from-cornerstone-fs/">AIM weekly movers: Another positive statement from Cornerstone FS</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-weekly-movers-another-positive-statement-from-cornerstone-fs/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: ValiRx licence deal and tinyBuild running out of money</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-valirs-licence-deal-and-tinybuild-running-out-of-money/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-valirs-licence-deal-and-tinybuild-running-out-of-money/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Tue, 05 Dec 2023 11:54:21 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Chaarat Gold]]></category>
		<category><![CDATA[Condor Gold]]></category>
		<category><![CDATA[Cornerstone FS]]></category>
		<category><![CDATA[Ethernity Networks]]></category>
		<category><![CDATA[Helium One Global]]></category>
		<category><![CDATA[Quiz]]></category>
		<category><![CDATA[Reabold]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<category><![CDATA[ValiRx]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=69871</guid>

					<description><![CDATA[<img width="300" height="199" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/09/ValiRx-cancer-treatment-testing-300x199.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/09/ValiRx-cancer-treatment-testing-300x199.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/09/ValiRx-cancer-treatment-testing-768x509.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/09/ValiRx-cancer-treatment-testing-633x420.jpg 633w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/09/ValiRx-cancer-treatment-testing-640x424.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/09/ValiRx-cancer-treatment-testing-681x452.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/09/ValiRx-cancer-treatment-testing.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Cancer treatments developer ValiRx (LON: VAL) has entered into an exclusive option agreement to licence VAL401 with Ambrose Healthcare. The option lasts for 12-months. A fee in the form of Ambrose Healthcare shares has been paid and there are milestone payments of up to £16m plus royalties. The share price jumped 24.1% to 12.25p. Condor [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-valirs-licence-deal-and-tinybuild-running-out-of-money/">AIM movers: ValiRx licence deal and tinyBuild running out of money</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-valirs-licence-deal-and-tinybuild-running-out-of-money/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Oxford BioDynamics validation and Anglo Asian Mining profit slump</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-oxford-biodynamics-validation-and-anglo-asian-mining-profit-slump/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-oxford-biodynamics-validation-and-anglo-asian-mining-profit-slump/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Tue, 26 Sep 2023 12:15:00 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Anglo Asian Mining]]></category>
		<category><![CDATA[Block Energy]]></category>
		<category><![CDATA[BowLeven]]></category>
		<category><![CDATA[eEnergy Group]]></category>
		<category><![CDATA[Oxford BioDynamics]]></category>
		<category><![CDATA[PCI-Pal]]></category>
		<category><![CDATA[Supreme]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=67907</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/06/Immunodiagnostic-Systems-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/06/Immunodiagnostic-Systems-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/06/Immunodiagnostic-Systems-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/06/Immunodiagnostic-Systems-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/06/Immunodiagnostic-Systems-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/06/Immunodiagnostic-Systems-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/06/Immunodiagnostic-Systems-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/06/Immunodiagnostic-Systems.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Oxford BioDynamics (LON: OBD) says the PSE prostate cancer test has completed validation in US CLIA laboratories earlier than expected. The test is available in the US and the UK, which will initially send the test to be processed in the US while accreditation is obtained in the UK. This adds to the company’s range [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-oxford-biodynamics-validation-and-anglo-asian-mining-profit-slump/">AIM movers: Oxford BioDynamics validation and Anglo Asian Mining profit slump</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-oxford-biodynamics-validation-and-anglo-asian-mining-profit-slump/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>AIM weekly movers: Revolution Beauty returns</title>
		<link>https://ukinvestormagazine.co.uk/aim-weekly-movers-revolution-beauty-returns/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-weekly-movers-revolution-beauty-returns/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Sun, 02 Jul 2023 17:19:41 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[boohoo]]></category>
		<category><![CDATA[DeepVerge]]></category>
		<category><![CDATA[MC Mining]]></category>
		<category><![CDATA[Microsaic Systems]]></category>
		<category><![CDATA[Renalytix]]></category>
		<category><![CDATA[Revolution Beauty]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<category><![CDATA[Trackwise Designs]]></category>
		<category><![CDATA[Unbound]]></category>
		<category><![CDATA[Woodbois]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=66126</guid>

					<description><![CDATA[<img width="300" height="286" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-300x286.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-440x420.jpg 440w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-640x610.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market-681x649.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2015/07/AIM-Market.jpg 885w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>On Thursday, Revolution Beauty (LON: REVB) shares recommenced trading following the AGM. It was suspended on 1 September 2022 because of the inability to publish accounts and concerns about the previous financial reporting. The AGM was eventful with an attempt to adjourn the meeting until the general meeting requisitioned by 27% shareholder boohoo failing. The [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-weekly-movers-revolution-beauty-returns/">AIM weekly movers: Revolution Beauty returns</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-weekly-movers-revolution-beauty-returns/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Renalytix FDA approval and share suspensions on the cards</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-renalytix-fda-approval-and-share-suspensions-on-the-cards/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-renalytix-fda-approval-and-share-suspensions-on-the-cards/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Fri, 30 Jun 2023 11:14:59 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[AMTE Power]]></category>
		<category><![CDATA[boohoo]]></category>
		<category><![CDATA[Caspian Sunrise]]></category>
		<category><![CDATA[Harvest Minerals]]></category>
		<category><![CDATA[Kropz]]></category>
		<category><![CDATA[Renalytix]]></category>
		<category><![CDATA[Revolution Beauty]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<category><![CDATA[Trackwise Designs]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=66097</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Renalytix-08042022-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Renalytix-08042022-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Renalytix-08042022-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Renalytix-08042022-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Renalytix-08042022-600x400.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Renalytix-08042022-696x464.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Renalytix-08042022-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/04/Renalytix-08042022.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Renalytix (LON: RENX) has been granted US FDA marketing authorisation for KidneyIntelX prognostic testing platform for kidney disease. This will lead to greater use in testing and insurance coverage. The share price jumped 50% to 112.5p. AMTE Power (LON: AMTE) was awarded a £389,000 grant by the UK Battery Industrialisation Centre yesterday. The company anticipates [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-renalytix-fda-approval-and-share-suspensions-on-the-cards/">AIM movers: Renalytix FDA approval and share suspensions on the cards</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-renalytix-fda-approval-and-share-suspensions-on-the-cards/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Ingenta contracts and ex-dividends</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-ingenta-contracts-and-ex-dividends/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-ingenta-contracts-and-ex-dividends/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Thu, 29 Jun 2023 10:39:19 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Falanx Group]]></category>
		<category><![CDATA[i3 Energy]]></category>
		<category><![CDATA[Ingenta]]></category>
		<category><![CDATA[Landore resources]]></category>
		<category><![CDATA[Pantheon Resources]]></category>
		<category><![CDATA[Premier African Minerals]]></category>
		<category><![CDATA[Science in Sport]]></category>
		<category><![CDATA[Symphony Environmental]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=66068</guid>

					<description><![CDATA[<img width="300" height="219" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/10/Pearson-share-Oct-22-300x219.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/10/Pearson-share-Oct-22-300x219.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/10/Pearson-share-Oct-22-768x561.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/10/Pearson-share-Oct-22-150x110.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/10/Pearson-share-Oct-22-600x439.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/10/Pearson-share-Oct-22-696x509.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/10/Pearson-share-Oct-22-575x420.jpg 575w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/10/Pearson-share-Oct-22-324x235.jpg 324w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/10/Pearson-share-Oct-22-648x470.jpg 648w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/10/Pearson-share-Oct-22.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Publishing software provider Ingenta (LON: ING) has won two contracts for its content distribution platform that are worth a total of £2m over five years. This underpins the expected growth for this year. The clients are a scientific publisher and a non-governmental organisation. A £1.4m pre-tax profit is forecast for 2023. The share price improved [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-ingenta-contracts-and-ex-dividends/">AIM movers: Ingenta contracts and ex-dividends</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-ingenta-contracts-and-ex-dividends/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: KCR Residential REIT discount and new low for Versarien</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-kcr-residential-reit-discount-and-new-low-for-versarien/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-kcr-residential-reit-discount-and-new-low-for-versarien/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Wed, 29 Mar 2023 12:17:52 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Coro Energy]]></category>
		<category><![CDATA[KCR Residential REIT]]></category>
		<category><![CDATA[Panthera Resources]]></category>
		<category><![CDATA[Personal Group Holdings]]></category>
		<category><![CDATA[SkinBioTherapeutics]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<category><![CDATA[Versarien]]></category>
		<category><![CDATA[Windward]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=63915</guid>

					<description><![CDATA[<img width="300" height="201" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Real-Estate-Investors-REIT-300x201.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Real-Estate-Investors-REIT-300x201.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Real-Estate-Investors-REIT-768x515.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Real-Estate-Investors-REIT-627x420.jpg 627w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Real-Estate-Investors-REIT-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Real-Estate-Investors-REIT-640x429.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Real-Estate-Investors-REIT-681x456.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/10/Real-Estate-Investors-REIT.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>KCR Residential REIT (LON: KCR) reported a reduction in net assets per share from 33p to 31.7p with potential for the revaluation of the Coleherne Road property. The share price rose 15.2% to 9.5p, which is a 70% discount to NAV. The market capitalisation is around £4m. Net debt was £11.4m at the end of [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-kcr-residential-reit-discount-and-new-low-for-versarien/">AIM movers: KCR Residential REIT discount and new low for Versarien</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-kcr-residential-reit-discount-and-new-low-for-versarien/feed/</wfw:commentRss>
			<slash:comments>983</slash:comments>
		
		
			</item>
		<item>
		<title>AIM movers: Physiomics completes study for dosing tool and poor Christmans for Frontier Developments</title>
		<link>https://ukinvestormagazine.co.uk/aim-movers-pysiomics-completes-study-for-dosing-tool-and-poor-christmans-for-frontier-developments/</link>
					<comments>https://ukinvestormagazine.co.uk/aim-movers-pysiomics-completes-study-for-dosing-tool-and-poor-christmans-for-frontier-developments/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Mon, 09 Jan 2023 11:43:25 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[Anpario]]></category>
		<category><![CDATA[Devolver Digital]]></category>
		<category><![CDATA[Frontier Developments]]></category>
		<category><![CDATA[GCM Resources]]></category>
		<category><![CDATA[musicMagpie]]></category>
		<category><![CDATA[Physiomics]]></category>
		<category><![CDATA[Poolbeg Pharma]]></category>
		<category><![CDATA[Renalytix]]></category>
		<category><![CDATA[Team 17]]></category>
		<category><![CDATA[tinyBuild]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=61817</guid>

					<description><![CDATA[<img width="300" height="199" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/AstraZeneca-shares-up-on-gastric-cancer-treatment-approval-300x199.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/AstraZeneca-shares-up-on-gastric-cancer-treatment-approval-300x199.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/AstraZeneca-shares-up-on-gastric-cancer-treatment-approval-768x510.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/AstraZeneca-shares-up-on-gastric-cancer-treatment-approval-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/AstraZeneca-shares-up-on-gastric-cancer-treatment-approval-600x398.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/AstraZeneca-shares-up-on-gastric-cancer-treatment-approval-696x462.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/AstraZeneca-shares-up-on-gastric-cancer-treatment-approval-633x420.jpg 633w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/AstraZeneca-shares-up-on-gastric-cancer-treatment-approval.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Physiomics (LON: PYC) has completed a grant-funded PARTNER study. This was an observational trial run by the University of Portsmouth that collected data from prostate cancer patients treated with docetaxel. The data will help clinicians make decisions about dosage. Physiomics is exploring other uses for its personalised dosing tool. The share price jumped by 88.7% [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/aim-movers-pysiomics-completes-study-for-dosing-tool-and-poor-christmans-for-frontier-developments/">AIM movers: Physiomics completes study for dosing tool and poor Christmans for Frontier Developments</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/aim-movers-pysiomics-completes-study-for-dosing-tool-and-poor-christmans-for-frontier-developments/feed/</wfw:commentRss>
			<slash:comments>3</slash:comments>
		
		
			</item>
	</channel>
</rss>
